Intelligent Bio Solutions Inc (NASDAQ:INBS)’s traded shares stood at 0.63 million during the last session, with the company’s beta value hitting 4.72. At the close of trading, the stock’s price was $2.12, to imply an increase of 8.72% or $0.17 in intraday trading. The INBS share’s 52-week high remains $11.70, putting it -451.89% down since that peak but still an impressive 52.83% since price per share fell to its 52-week low of $1.00. The company has a valuation of $10.19M, with an average of 0.28 million shares in intraday trading volume over the past 10 days and average of 150.68K shares over the past 3 months.

Intelligent Bio Solutions Inc (NASDAQ:INBS) trade information

After registering a 8.72% upside in the last session, Intelligent Bio Solutions Inc (INBS) has traded red over the past five days. The 5-day price performance for the stock is 20.45%, and 48.25% over 30 days. With these gigs, the year-to-date price performance is 51.43%. Short interest in Intelligent Bio Solutions Inc (NASDAQ:INBS) saw shorts transact 0.37 million shares and set a 1.25 days time to cover.

INBS Dividends

Intelligent Bio Solutions Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Intelligent Bio Solutions Inc (NASDAQ:INBS)’s Major holders

Intelligent Bio Solutions Inc insiders hold 3.02% of total outstanding shares, with institutional holders owning 14.38% of the shares at 14.83% float percentage. In total, 14.38% institutions holds shares in the company.

We also have Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Intelligent Bio Solutions Inc (INBS) shares. Going by data provided on Nov 30, 2024 , Fidelity Extended Market Index Fund holds roughly 17.52 shares. This is just over 0.40% of the total shares, with a market valuation of $37152.0. Data from the same date shows that the other fund manager holds a little less at 15.48, or 0.35% of the shares, all valued at about 32828.0.